|
THE RISE OF VIRTUAL CLINICAL TRIALS
COVID-19 has amplified the industry's need for virtual trial capabilities. Sponsors, CROs, and other members of the biopharmaceutical industry are adapting at a rapid pace. What can we expect as we enter this new era of clinical development?
Join a broad panel of industry experts for an interactive Trial Better Live briefing on the potential and limitations of trial virtualization. They’ll also cover:
The impact of virtual trials on patient consent
The continued role of disruptive innovation post-COVID
Insights from a recently-completed industry survey on the increased use of virtual trial capabilities
Join us on May 20 and add your voice to the discussion.
|
